AdvisorShares Pure US Cannabis ETF (MSOS)
| Assets | $973.02M |
| Expense Ratio | 0.97% |
| PE Ratio | 12.20 |
| Shares Out | 197.97M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| Volume | 19,543,738 |
| Open | 4.970 |
| Previous Close | 4.880 |
| Day's Range | 4.500 - 5.010 |
| 52-Week Low | 2.020 |
| 52-Week High | 7.250 |
| Beta | 1.08 |
| Holdings | 117 |
| Inception Date | Sep 1, 2020 |
About MSOS
Fund Home PageThe AdvisorShares Pure US Cannabis ETF (MSOS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. MSOS was launched on Sep 1, 2020 and is issued by AdvisorShares.
Top 10 Holdings
95.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Derivatives Collateral Nomura | n/a | 19.42% |
| Curaleaf Holdings Inc Swap | n/a | 14.37% |
| Green Thumb Industries Swap | n/a | 13.09% |
| Curaleaf Holdings, Inc. | CURA | 10.51% |
| Blackrock Treasury Trust Instl 62 | n/a | 9.14% |
| Trulieve Cannabis Swap | n/a | 7.21% |
| Trulieve Cannabis Swap | n/a | 7.15% |
| Derivatives Collateral Nbc | n/a | 5.51% |
| Derivatives Collateral Cf Secured | n/a | 4.82% |
| Derivatives Collateral Marex | n/a | 4.11% |
Performance
MSOS had a total return of 22.37% in the past year, including dividends. Since the fund's inception, the average annual return has been -27.58%.
News
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling...
Undercovered Dozen: Canadian Natural Resources, Duke Energy, PennyMac Mortgage And More
This week's Undercovered Dozen highlights 12 lesser-followed stocks and funds, each with distinct catalysts or value opportunities. This week's edition covers articles published between Dec. 12 and De...
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe...
Trump signs executive order to reschedule cannabis. Here's what's next
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...
Cannabis Investing In The Trump Era
Josh Rosen and Jerry Derevyanny from Bengal Capital discuss the current state of cannabis investing. Federal regulatory changes, including Trump's executive order, are unlikely to materially impact ca...
Cannabis companies face hurdles accessing big banks despite reclassification, experts say
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Trulieve CEO Kim Rivers reacts to marijuana being reclassified
Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.
Trump signed an executive order to reclassify marijuana.
About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage ...
AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis
MSOS portfolio manager calls executive action a pivotal moment for cannabis policy BETHESDA, Md. , Dec. 18, 2025 /PRNewswire/ -- AdvisorShares, a leading sponsor of actively managed exchange-traded fu...
Donald Trump Has Officially Reclassified Marijuana To A Schedule 3 Substance
It has officially happened, Donald J Trump has signed the executive order to reschedule cannabis. Now, cannabis has been taken from a Class 1 to a Class 3 substance under the Controlled Substances. At...
Trump signs executive order on marijuana reclassification; cannabis shares rally
President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III. The move sent US cannabis stocks sharply higher on expe...
President Trump signs executive order to reclassify marijuana, easing federal restrictions
President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.
Trump Signs Order Easing Federal Restrictions on Marijuana
President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how th...
Tilray and Cannabis Stocks Soar Ahead of Expected Trump Executive Order on Marijuana
Shares of Tilray Brands and other cannabis stocks are rising ahead of President Donald Trump's executive order signing ceremony.
Marijuana stocks jump, with Trump set to sign executive order that would reclassify the drug
Tilray and Canopy Growth shares are among big gainers Thursday.
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will sign an executive order easing federal regulations on marijuana.
Explainer: What will change if the US reclassifies marijuana?
U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research that could lead to new medical marijuana products. Here is ...
Cannabis ETFs: This Imminent Trigger Could Lead To A Definitive Repricing Of Assets
I recommend buying cannabis sector ETFs. Recent news suggests imminent U.S. regulatory easing, potentially reclassifying marijuana and unlocking significant sector value. Current MJ ETF price/sales is...
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling
Cannabis stocks rallied Wednesday morning following fresh reports that President Donald Trump is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III.
Trump expected to sign executive order to fast-track reclassification of cannabis, NBC News reports
U.S. President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis, NBC News reported on Tuesday, citing four people with di...
Trump's Giving Cannabis Stocks a Lift—and the Optimism May Be Justified
After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease.
Pot stocks keep blazing, after Trump says he's ‘very strongly' looking at rescheduling cannabis
Shares of U.S. and Canadian cannabis stocks continued their rally on Tuesday, after President Donald Trump a day earlier said he was “very strongly” weighing an executive order to reschedule the drug,...
Trump again says he is considering reclassifying marijuana as less dangerous drug
President Donald Trump said he is considering an executive order to reclassify marijuana as Schedule III drug, citing research benefits and public demand for policy reform.
Trump says he's 'strongly' considering reclassifying pot via executive order
President Donald Trump confirmed he's considering an executive order loosening regulations on marijuana. Pot stocks fell on Monday as investors took profits following a record-setting session.
Trump says he is considering executive order to reclassify marijuana
President Donald Trump said on Monday he is considering signing an executive order to reclassify marijuana as a less dangerous drug.
5 ETFs to Watch as Restrictions on Marijuana Set to Ease
Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. ...
Cannabis stocks spike on reports Trump plans to ease federal pot restrictions
The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.
Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?
Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate...
Trump Expected to Label Pot a Less Dangerous Drug
President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the in...
Cannabis stocks surge on report Trump seeks to ease restrictions.
President Donald Trump is expected to push for marijuana reclassification from Schedule I to Schedule III status, sending cannabis stocks soaring.
MSOS: Focused Exposure To U.S. Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF offers concentrated, actively managed exposure to the US cannabis industry via equities and swaps. MSOS is top-heavy, with 97% of net assets in its top 10 positi...
Marijuana ETFs Look to Supreme Court Legalization
Thematic ETFs have a long and storied history in the ETF ecosystem, offering investors ways to make sector bets, for example, or, craft a bespoke allocation with individual building blocks.
MSOS Has HEMP THC Prohibition Issues
I maintain a Strong Sell on AdvisorShares Pure US Cannabis ETF due to excessive volatility and structural portfolio risks. MSOS is heavily concentrated, with 69% exposure to Curaleaf, Green Thumb Indu...
'Green Wednesday': A high holiday for cannabis before Thanksgiving
Cannabis has carved out it's own holiday shopping rush and it's called "Green Wednesday". Behind April 20, the day before Thanksgiving has become the second-biggest day for cannabis sales in the U.S. ...
Cannabis stocks soar after Trump shares video promoting drug's use for seniors
Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products
Cannabis stocks move higher after Trump boasts CBD health benefits
Cannabis stocks got a pop on Monday after President Trump shared a video highlighting potential health benefits of CBD, reigniting speculation that his administration could reclassify the drug, CNBC's...
President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post
President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in fed...
Quant Buys In Cannabis
Cannabis has bipartisan support, but is it worthy of your investment? Quant Strategist Emma Johnston on how quant thinks about sector ETF MSOS, currently rated a buy due to strong momentum and liquidi...
MSOS: Cannabis Investors Betting Big On Trump
Optimism that the Trump administration will soon reschedule cannabis, thereby removing the Section 280E tax burden and boosting sector profitability, has fueled a dramatic rally in cannabis stocks. MS...
Rescheduling Should Send MJ And MSOS Sky High
Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. R...
Cannabis stocks rally after Trump says he is weighing drug reclassification
Cannabis stocks rallied Monday after President Donald Trump said he is considering reclassifying marijuana, which would categorize it as less of a danger to public safety.
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the ind...
MSOS: Headed For A New All-Time Low
MSOS has significantly underperformed the broader cannabis market, dropping 41.2% YTD versus a 27.8% sector decline. I downgraded MSOS to Strong Sell in April due to persistent risks, and the ETF has ...
MSOS ETF Underperforms Compared To Canadian Cannabis Peers
MSOS holds US cannabis MSOs exclusively. It allows for exposure to US cannabis companies. US MSO stocks are historically down.
MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ...
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out
Veteran hedge fund manager Doug Kass isn't mincing words about the state of the cannabis industry. In a recent column titled “Picking the Cannabis Winners in an Industry Full of the Walking Dead,” the...